Author: openjargon

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is in focus today after the company announced its brain cancer imaging drug, Pixclara, has won approval from the US FDA—making it the first FET-PET imaging drug cleared for use in glioma and expanding Telix’s precision medicine portfolio.

What did Telix Pharmaceuticals report?

• FDA approved Pixclara® (floretyrosine F 18), for imaging gliomas (brain cancer) in adult and paediatric patients
• Pixclara is the first FDA-approved FET-PET imaging drug for glioma
• Pixclara’s approval addresses a significant unmet need in US brain cancer diagnostics
• Product expansion reinforces Telix’s position in precision diagnostics and targeted radiopharmaceutical “theranostics”

What else do investors need to know?

Pixclara is the only FDA-approved radiopharmaceutical imaging drug specifically for glioma, a difficult-to-treat brain cancer representing around 24,000 new cases annually in the US. The new drug is indicated for adults and children as young as one month old and is expected to support better treatment decision-making for both clinicians and patients.

The approval also makes Pixclara eligible for widespread clinical use. FET-PET imaging has been recommended in various international guidelines, but until now, there was no FDA-approved product available in the United States. Telix already has other FDA-approved imaging offerings and is working on advancing late-stage therapies across multiple cancers.

What did Telix Pharmaceuticals management say?

Kevin Richardson, Chief Executive Officer, Telix Precision Medicine, said:

FDA approval of Pixclara will enable broad access in the U.S. to FET-PET imaging, which is already recognized in international clinical practice guidelines. As the first FDA-approved PET imaging drug for glioma, Pixclara will provide physicians in the U.S. with more certainty in their diagnoses and greater confidence in their treatment planning for patients.

What’s next for Telix Pharmaceuticals?

Telix says Pixclara is already the subject of a Phase 3 trial for diagnosis in additional brain conditions, with potential expansion to brain metastases. The company continues to leverage its global diagnostics platform and late-stage radiopharmaceutical pipeline to target market leadership in both imaging and treatment for several high-need cancers.

Telix’s broader pipeline includes late-stage assets in prostate, kidney, and glioblastoma cancers, with a focus on bringing further precision medicine products to both existing and new markets worldwide.

Telix Pharmaceuticals share price snapshot

Over the past 12 months, Telix shares have risen 12%, outperforming the S&P/ASX 200 Index (ASX: XJO), which has declined 1% over the same period.

View Original Announcement

The post Telix Pharmaceuticals shares: FDA approves Pixclara brain cancer drug appeared first on The Motley Fool Australia.

More reading

• Forget CSL shares. 3 ASX healthcare stocks with bigger upside
• CSL led the ASX healthcare shares rebound. Can it continue?
• 4 high conviction ASX stock picks from Canaccord Genuity
• Telix shares are up 98%: Is there more upside to come?
• Telix shares are tumbling. Is the stock finally at fair value?

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Cleanaway Waste Management Ltd (ASX: CWY) share price is in focus following its latest update on the proposed EQT Infrastructure acquisition. EQT has restated its intent to proceed without any negative changes to its initial indicative price, giving shareholders renewed confidence in the ongoing scheme discussions.

What did Cleanaway Waste Management report?

• EQT Infrastructure confirmed nothing in its due diligence would cause it to withdraw or reduce its indicative proposal.
• No less favourable terms are proposed for Cleanaway shareholders.
• The offer consideration remains at least at the previously indicated level.
• The hard exclusivity period under the Transaction Process Deed has ended as planned.
• Both parties are working toward an implementation deed but no binding agreement has been reached yet.

What else do investors need to know?

EQT Infrastructure has finished its agreed exclusivity period for reviewing Cleanaway, but remains engaged and positive about progressing the transaction. The proposal is still indicative and non-binding, meaning there is no guarantee it will result in a formal offer.

Shareholders are not required to take any action currently. Cleanaway’s board has assured investors that they will provide further updates as developments occur. The Board’s proactive communication helps keep everyone in the loop on this potential change in ownership.

What’s next for Cleanaway Waste Management?

The next key step will be finalising due diligence and entering into an implementation deed—if terms can be agreed—so shareholders can consider a definitive proposal. Cleanaway continues operating as usual, maintaining its commitment to service, sustainability, and shareholder value.

With the deal still unconfirmed, investors should watch future announcements closely for any advances, revised offers, or changes in EQT’s intentions.

Cleanaway Waste Management share price snapshot

Over the past 12 months, Cleanaway shares have declined 9%, trailing the S&P/ASX 200 Index (ASX: XJO), which has declined 1% over the same period.

View Original Announcement

The post Cleanaway Waste Management provides EQT bid update appeared first on The Motley Fool Australia.

More reading

• 40 ASX shares with ex-dividend dates next week
• Cleanaway FY26: earnings rise, dividend up, takeover bid in play

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Wesfarmers Ltd (ASX: WES) shares have been a solid choice for growing wealth over the last several years. We’re going to consider whether the company can deliver good returns from here.

Wesfarmers is best known as the owner of Bunnings Group (which includes Beaumont Tiles) and Kmart Group (which includes Anko and Target).

The company has several businesses in its portfolio, including chemicals, energy, a fertiliser business called WesCEF, and its healthcare segment, which includes Priceline and InstantScripts.

The company recently reported its FY26 result, which gave investors insights into its performance and helps figure out what the investment’s underlying value.

FY26 earnings recap

For the 12 months to 30 June 2026, the business reported revenue growth of 3.4% to $47.3 billion.

Overall, Bunnings Group revenue grew 4.1% to $20.4 billion, Kmart Group revenue rose 2.8% to $11.75 billion, WesCEF revenue increased 5.9% to $3.1 billion, Officeworks revenue rose 3.7% to $3.7 billion, and healthcare revenue grew 9.1% to $6.5 billion.

Turning to profitability, underlying operating profit (EBIT) rose 7.3% to $4.5 billion, and underlying net profit increased 8.3% to $2.87 billion.

In terms of divisional earnings, Bunnings Group earnings before tax (EBT) rose 5.1% to $2.45 billion, Kmart Group EBT climbed 6% to $1.1 billion, WesCEF EBT increased 18.5% to $473 million, Officeworks EBT declined 22.2% to $165 million and the Wesfarmers healthcare division EBT increased 18.8% to $76 million.

Given the challenging retail conditions, I think the company delivered an impressive performance.

Its trading update was promising, with commentary suggesting that sales growth has continued for Kmart and Bunnings in the first seven weeks of FY27.

Given its market-leading position in affordable hardware and general merchandise, I think the business is well positioned for the current economic climate.

What could happen with a $10,000 investment in Wesfarmers shares?

According to CMC Invest, there have been 11 analyst ratings on the company within the last three months.

Of those 11 expert ratings, the average price target is $78.13. A price target is where analysts think the (Wesfarmers) share price will go in 12 months from the time of the investment call.

The average price target of $78.13 implies the Wesfarmers share price could rise by 7.3% over the next year. Therefore, a $10,000 investment could grow to $10,700, which would be solid return, in my opinion.

On top of that, the business could pay an annual dividend per share of $2.40 in FY27, according to CMC Invest. That could translate into a grossed-up dividend yield of 4.7%, including franking credits.

Overall, investors in Wesfarmers could see a $10,000 investment turn into more than $11,000 of total wealth within the next 12 months. That could be a solid investment, but there could be even better ASX share buys available.

The post By September 2027, Wesfarmers shares could turn $10,000 into… appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Corporate Travel Management, Wesfarmers, Fortescue shares
• How to build a superannuation portfolio generating $50,000 a year
• With no savings at 50, I’d follow Warren Buffett’s approach to build wealth
• 3 reasons why the Wesfarmers share price is a buy
• How much is needed in superannuation to target a $70,000 annual passive income?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When investors think about huge market winners, Nvidia Corp (NASDAQ: NVDA) is one of the first stocks that comes to mind.

But I’m not sure many investors would have picked an oil shipping ETF to be sitting near the top of the list.

The Breakwave Tanker Shipping ETF (NYSEMKT: BWET) finished Friday at US$726.92 after gaining another 11.83%.

It is now up around 3,670% in 2026.

Yes, you read that correctly.

To put that into perspective, $10,000 invested at the start of the year would now be worth around $377,000, before fees and taxes.

And those gains haven’t come from AI, crypto, or the latest hot tech stock.

Instead, it has benefited from the soaring cost of moving oil around the world.

So, what exactly is BWET?

BWET is a pretty unusual ETF.

It doesn’t own oil tankers, and it doesn’t invest in shipping companies either.

Instead, the fund invests in freight futures, which rise and fall with the cost of transporting oil by tanker.

A large part of that exposure is linked to the cost of shipping oil from the Middle East to China on super tankers.

And that is where things have really taken off this year.

The war involving the US and Iran has disrupted traffic through the Strait of Hormuz.

At the same time, problems around the Red Sea have made some shipping routes longer, more difficult, and much more expensive.

Some vessels have been forced to take longer routes, while others have avoided certain areas altogether.

The result has been a huge jump in tanker freight rates.

And because BWET is tied to those freight prices, the ETF has taken off with them.

The fund is up around 46% in just the past week, 113% over 1 month and more than 1,000% over the past 6 months.

There’s a catch

As good as those returns look, BWET definitely isn’t the type of ETF most investors would want to buy and forget about for the next 20 years.

Freight rates can move very quickly, and that works both ways.

If shipping routes reopen, geopolitical tensions calm, or more vessels become available, those huge freight prices could come down quickly.

We’ve already seen how quickly BWET can turn.

Earlier this year, the ETF fell more than 40% in just 2 weeks as investors became more hopeful about peace talks.

There’s also the cost to consider.

BWET has an expense ratio of 3.5%, which is very high compared with a typical broad-market ETF.

What investors can learn from this

BWET is probably one of the strangest success stories on the market this year.

At the start of 2026, it was a tiny ETF that most investors had probably never heard of.

Now, it is the best-performing non-leveraged US ETF by a huge margin.

Of course, that doesn’t mean investors should suddenly start chasing tanker freight futures.

It’s a good reminder to keep looking ahead, because the next big opportunity isn’t always where everyone else is looking.

The post Forget Nvidia. This little-known ETF is up more than 3,600% in 2026 appeared first on The Motley Fool Australia.

More reading

• Should I buy the iShares Global 100 ETF (IOO) now?
• You don’t need to own Nvidia to invest in AI – Here are the best Aussie artificial intelligence shares
• This ASX stock could be a surprise winner of the AI boom
• These are the 10 richest people in the world in September
• ASX shares investors are getting younger and trading more often: CBA report

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Nvidia. The Motley Fool Australia has recommended Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

There are a range of potential ASX share opportunities Australians can buy. Some of them are well-liked by analysts.

When one expert likes a business, that’s interesting. When numerous analysts think a stock is a buy, that could signify there’s an appealing opportunity for investors.

While brokers aren’t unanimous on the stocks below, some experts predict they could deliver strong returns.

Regis Healthcare Ltd (ASX: REG)

Regis describes itself as one of the largest aged care operators in Australia. It provides services to more than 10,000 older Australians through residential aged care homes, home care service hubs, day therapy and respite centres, and retirement villages.

The company recently noted that the Australian national aged care classification (AN-ACC) starting price will increase 2.55% to $303.19 starting 1 October 2026. However, the company thinks that the AN-ACC starting price is significantly below the prevailing cost inflation across the sector and the broader economy.

Regis is undertaking a range of initiatives to mitigate ongoing margin pressure related to government funding settings. This includes raising room prices, rolling out higher everyday living fee (HELF) services, and other revenue optimisation and operational efficiency initiatives.

In FY26, revenue from services grew 16% to $1.35 billion and statutory net profit grew 14% to $55.7 million. This helped total FY26 dividends grow by 13% to 18.4 cents per share.

According to CMC Invest, there have been six analyst ratings on the ASX share in the last three months, with two of those being buys, and four of them being holds.

The average price target from those analysts is currently $6.08, which suggests a possible 34% gain over the next year for the ASX share.

Superloop Ltd (ASX: SLC)

The other ASX share I want to highlight is an ASX telco share. The business offers three segments – consumer, business and wholesale. It provides NBN connections and owns and operates extensive fibre-to-the-premises (FTTP) and managed Wi-Fi networks that serve residential and commercial communities.

Superloop reported strong growth metrics in FY26, with 21.6% revenue growth to $664.3 million, gross profit growth of 23.8% to $234.8 million, underlying operating profit (EBITDA) growth of 33.1% to $122.7 million and underlying net profit (NPATA) growth of 34.2% to $37.9 million. It also reported free cash flow growth of 50% to $84.4 million.

The ASX share’s customer base continues to improve. Its number of customers improved by 28% to 935,000, while its NBN market share increased 1.9 percentage points to 8.5% during FY26.

By FY29, the ASX share is targeting $1 billion of revenue, $200 million of underlying EBITDA and a compound annual growth rate (CAGR) of reported earnings per share (EPS) of more than 30%.

According to CMC Invest, there have been seven ratings on the business within the last three months, with five ratings buys and two holds. The average price target of those analysts is $3.82, suggesting a possible 42% gain over the next 12 months.

The post 2 ASX shares tipped to grow 30% or more in the next 12 months appeared first on The Motley Fool Australia.

More reading

• 2 ASX shares tipped by brokers to return 25% and 42%
• Why investors should be targeting ASX mid-caps and ASX small-caps after earnings season: Expert
• 9 ASX shares downgraded by experts post-results this week
• 40 ASX shares with ex-dividend dates next week
• Regis Healthcare reacts to government funding change

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

I think one of the best things we can do for our children financially, aside from teaching them about money, is to invest in ASX shares for the long term and let compounding work its magic.

As a family, we like to occasionally invest for our child’s future. At some point, that money can provide for them in some way, whether that’s a lump sum for a specific purpose or regular dividends to contribute towards certain things.

For multiple reasons, we decided to invest in Future Generation Global Ltd (ASX: FGG).

Diversification

Future Global Generation is a listed investment company (LIC) that’s invested in the funds of more than a dozen fund managers. Some of the fund managers include Vinva, Life Cycle, Cooper Investors, Antipodes, Plato and Paradice.

That means the ASX share can provide investors like me with good diversification. The portfolio is invested in more than 3,000 underlying securities, which is amazing diversification in my view.

The portfolio is spread across a number of geographic regions, making it pleasingly diversified by market as well. Around half of the portfolio is invested in North America, approximately a fifth is invested in the UK and Europe, close to 10% is invested in Asia, approximately 5% in other developed markets, around 1% in emerging markets, and the rest is a cash position.

One of the most appealing aspects of Future Generation Global is that it donates 1% of its net assets to youth mental health charities. Some of the charities it supports include Youth Opportunities, Prevention United, Back Track, Big hArt, Happy Paws Happy Hearts and Smiling Mind.

Dividends

Future Generation Global is one of the most compelling ASX dividend shares around, in my view. It offers an attractive combination of a good dividend yield and rising payouts.

The business has steadily increased its annual payout each year since FY19. Many large ASX shares haven’t delivered consistent payout growth this decade amid COVID-19 and inflation headwinds.

The business has guided its regular dividend is going to be hiked by 5% to 8.4 cents per share. That translates into a grossed-up dividend yield of 7.5%, including franking credits, at the time of writing.

Few ASX businesses have a dividend yield that high and have increased their payout for as many years in a row.

If I want to access the dividends over time, then this is a very rewarding choice.

Total shareholder returns

A key reason why I wanted to choose this ASX share with my child in mind is that it’s a great choice for long-term compounding. By reinvesting the dividends, I think our Future Generation Global holding can increase in value.

The total shareholder return (TSR) measure tells investors how much of a return an investment has made when we include both the dividends and the capital growth.

Past performance is not a guarantee of future returns of course, but Future Generation Global has delivered an average TSR of 16.8% per year in the last three years and an average of 7.8% per year over the past decade.

This return is strong enough to help deliver pleasing compound growth over time.

The post The ASX share I just bought for my child appeared first on The Motley Fool Australia.

More reading

• How much is needed in superannuation to target a $60,000 annual passive income?
• 2 ASX passive income ideas I’d use to generate $700 a month in 2027
• 3 ASX dividend shares raising dividends like clockwork
• How much is needed in superannuation to target a $2,500 monthly passive income?
• How much do I need to retire on $120,000 a year at 55?

Motley Fool contributor Tristan Harrison has positions in Future Generation Global. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Deciding which ASX shares are buys and which ones are sells can be difficult. 

To help you figure things out, let’s look at three ASX shares that experts are tipping as sells this week, courtesy of The Bull. 

Here’s what they are saying:

Commonwealth Bank of Australia (ASX: CBA)

Shaw and Partners has named this big four bank as an ASX share to sell this week.

It highlights that CBA shares continue to trade at a significant premium to peers despite its subdued earnings growth outlook. It said:

In our view, the stock trades at a significant premium to domestic peers and on historical valuations. While the bank maintains a high quality franchise and strong market position, earnings growth is expected to remain modest amid competitive lending conditions and regulatory pressures. 

Recent Federal Government initiatives aimed at increasing housing supply and improving affordability is likely to lead to intensifying competition across the mortgage market and place pressure on lending margins. Current valuations leave limited scope for further earnings driven upside. Investors may wish to take profits and re-deploy capital into opportunities offering stronger risk-adjusted return potential.

Fortescue Ltd (ASX: FMG)

The team at RaaS Group has named iron ore giant Fortescue as an ASX share to sell.

It thinks the outlook for iron ore is less appealing than other commodities. It said:

The iron ore producer generated revenue of $US16.966 billion in full year 2026, up 9 per cent on the prior corresponding period. Statutory net profit after tax of $US2.860 billion was down 15 per cent, which included a $US525 million non-cash impairment charge relating to the Iron Bridge project and a $US73 million compensation claim expense. The final, fully franked dividend of 46 cents a share was down from 60 cents a year ago. 

Capital expenditure and investment guidance in full year 2027 is forecast to increase on full year 2026. The outlook for the iron ore price isn’t as appealing as other commodities. The share price has fallen from $22.99 on May 14 to trade at $17.22 on September 10.

Woolworths Group Ltd (ASX: WOW)

Shaw and Partners has also named supermarket giant Woolworths as an ASX share to sell.

While it acknowledges that Woolworths is a quality business, it thinks investors should be taking profit after a recent rally and focusing on investments with a more attractive risk-reward profile. Shaw and Partners said:

The supermarket group has experienced a strong recovery in the past year, with the share price recently trading near the upper end of its historical range. While the company remains high quality with a leading position in Australian food retailing, much of the recent improvement appears to be reflected in the WOW share price. Earnings growth is expected to remain relatively steady rather than exceptional, limiting scope for further share price appreciation from current levels. 

Following the recent rally, investors may consider taking profits before re-allocating capital to opportunities with stronger growth potential and a more attractive risk-reward profile.

The post Experts name CBA and these big-name ASX 200 shares as sells this week appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Corporate Travel Management, Wesfarmers, Fortescue shares
• How to build a superannuation portfolio generating $50,000 a year
• Buy, hold, sell: NextDC, South32, CBA shares
• Are ASX shares heading for a crash? Here’s how I’m preparing
• $10,00 invested in Rio Tinto and Fortescue shares 3 years ago is now worth…

Motley Fool contributor James Mickleboro has positions in Woolworths Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are looking for new additions to your portfolio, then it could be worth listening to what analysts are saying about the popular ASX shares named below, courtesy of The Bull. 

Here’s what they are recommending this week:

Aurizon Holdings Ltd (ASX: AZJ)

The team at Baker Young has named this rail freight operator as an ASX share to buy this week.

It likes Aurizon due to its positive outlook and attractive dividend yield. Baker Young said:

This coal and freight logistics firm delivered better than expected full year 2026 results, in our view. Revenue of $4.194 billion was up 6 per cent on the prior corresponding period and statutory net profit after tax of $362 million was up 19 per cent. A highly encouraging performance at its containerised freight division provides a long term opportunity, in our view. 

Strong global coal prices amid favourable weather conditions to date in New South Wales and Queensland should generate demand for export logistics. While competition for haulage contracts may lower margins, the business outlook remains positive. It was recently trading on an attractive dividend yield above 6 per cent.

NextDC Ltd (ASX: NXT)

Over at Shaw and Partners, its analysts have named data centre operator NextDC as an ASX share to buy.

It highlights that NextDC continues to benefit from strong demand for data centre infrastructure, which is being driven largely by the artificial intelligence boom.

The good news is that Shaw and Partners believes these structural growth tailwinds will persist for many years. It said:

The company continues to benefit from strong demand for data centre infrastructure, driven by cloud computing, artificial intelligence and increasing digitalisation across the economy. NXT is expanding capacity across key Australian markets and maintains a strong development pipeline to support future growth. 

While investment spending remains elevated, management continues to secure long term customer contracts that provide earnings visibility. With structural growth tailwinds expected to persist for many years, NXT remains well positioned to deliver attractive long term shareholder returns.

Temple & Webster Group Ltd (ASX: TPW)

Baker Young has also named online furniture and homewares retailer Temple & Webster as an ASX share to buy this week.

It is feeling upbeat on the investment opportunity here following a leadership change and its positive medium term growth outlook. It explains:

We don’t regularly play high growth consumer discretionary stocks, but we see an opportunity emerging in this online furniture and homewares retailer. The company delivered record revenue of $664.6 million in full year 2026, up 10.6 per cent on the prior corresponding period. It’s worth noting that new chief executive Susie Sugden was previously the chief marketing officer during the company’s highly successful infancy between 2016 and 2020. The company is focusing on improving margins, which, in our view, is conservative and prudent given the incredibly challenging conditions in the retail sector. 

We believe new management deserves an opportunity to rebase expectations in a sector offering medium term upside. Also, we believe accumulating a position is worth considering for those willing to take relatively high volatility risk.

The post Experts name 3 top ASX shares to buy this week appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Monday
• Buy, hold, sell: NextDC, South32, CBA shares
• 2 ASX shares I’d buy before they return to their 52-week highs
• 3 ASX shares with dividend yields of between 6% and 11%
• NEXTDC shares are falling despite $1.1 billion funding boost. Here’s why

Motley Fool contributor James Mickleboro has positions in Nextdc and Temple & Webster Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Temple & Webster Group. The Motley Fool Australia has recommended Temple & Webster Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares fell by almost 3% last week amid soaring oil prices and higher bond yields.

The ASX 200 closed at a 10-week low of 8,741.2 points on Friday.

Here are some fresh stock ratings from the experts.

Corporate Travel Management Ltd (ASX: CTD)

The Corporate Travel Management share price increased 9.33% to $2.46 last week.

Corporate Travel Management resumed trading on 3 September after reporting its audited FY25 and FY26 figures.

The stock was suspended in August last year.

Morgans resumed coverage of this ASX travel share with a buy rating and a 12-month price target of $3.06.

The broker said: 

Material earnings restatements have been made. Following years of overcharging clients, CTD will refund them A$246m by 30 September 2027, supported by its new A$175m debt facility. FY27 guidance will be provided at the AGM.

We forecast earnings to fall materially due to a higher AUD, reduced special project work and higher corporate costs. Earnings growth should resume from FY28 given new management’s strategy.

The acceleration of new client wins in the first two months of FY27 is encouraging.

Given what has gone on, it will take time for confidence to rebuild and risks remain. However, we think CTD is a turnaround story under new leadership with material upside potential if it executes.

Wesfarmers Ltd (ASX: WES)

The Wesfarmers share price fell 6.32% to $72.82 last week.

James Bills from Shaw and Partners has a hold rating on this ASX 200 consumer discretionary share. 

Bills said (courtesy The Bull):

Wesfarmers remains one of Australia’s premier diversified companies. It’s supported by market leading businesses, including Bunnings, Kmart and Officeworks.

The company’s strong balance sheet, disciplined capital allocation and resilient earnings profile continue to underpin shareholder value.

While growth opportunities remain available across several divisions, recent share price levels appear to reflect much of this quality.

Holding Wesfarmers remains appropriate given the company’s strong market position, dependable cash generation and proven ability to create value over the long term.

Fortescue Ltd (ASX: FMG)

The Fortescue share price declined 3.19% to $16.67 last week.

Joshua Baker from RaaS Group has a sell rating on this ASX 200 mining share. 

Baker said: 

The iron ore producer generated revenue of $US16.966 billion in full year 2026, up 9 per cent on the prior corresponding period.

Statutory net profit after tax of $US2.860 billion was down 15 per cent, which included a $US525 million non-cash impairment charge relating to the Iron Bridge project and a $US73 million compensation claim expense.

The final, fully franked dividend of 46 cents a share was down from 60 cents a year ago.

Capital expenditure and investment guidance for full year 2027 is forecast to increase over full year 2026.

The outlook for the iron ore price isn’t as appealing as other commodities.

The share price has fallen from $22.99 on May 14 to $17.22 on September 10.

The post Buy, hold, sell: Corporate Travel Management, Wesfarmers, Fortescue shares appeared first on The Motley Fool Australia.

More reading

• Experts name CBA and these big-name ASX 200 shares as sells this week
• How to build a superannuation portfolio generating $50,000 a year
• Top brokers name 3 ASX shares to buy next week
• With no savings at 50, I’d follow Warren Buffett’s approach to build wealth
• $10,00 invested in Rio Tinto and Fortescue shares 3 years ago is now worth…

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Corporate Travel Management and Wesfarmers. The Motley Fool Australia has positions in and has recommended Corporate Travel Management. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

For retirees, building a portfolio of quality ASX dividend shares could provide a valuable income stream alongside superannuation, while retaining potential for long-term growth.

Super remains a cornerstone of retirement planning, but a diversified basket of dividend-paying companies may give investors greater flexibility and regular cash flow.

Start with dependable income

A successful superannuation portfolio isn’t necessarily about chasing the highest dividend yields. Instead, investors should look for companies with resilient earnings, sustainable payouts and the potential to grow dividends over time.

Woolworths Group Ltd (ASX: WOW) is one example. Supermarkets may not be the most exciting businesses, but Australians continue buying groceries and household essentials through different economic conditions.

Diversification is also important. Building a portfolio dominated by banks or miners can create significant exposure to a particular part of the economic cycle.

Add infrastructure income

APA Group (ASX: APA) could provide another source of diversification for the superannuation portfolio.

APA owns and operates energy infrastructure, including gas pipelines and renewable energy assets. That means its revenue is linked more closely to essential infrastructure and contracted arrangements than simply the underlying commodity price.

For an income-focused portfolio, adding businesses with different earnings drivers can help reduce reliance on any single sector.

Look for dividend consistency

There aren’t many ASX companies with a dividend history quite like Sonic Healthcare Ltd (ASX: SHL).

The healthcare giant has paid dividends since 1994 and has increased its payout almost every year since then. The exceptions were 2011 and 2012, when Sonic maintained rather than increased its dividend.

In FY26, Sonic continued its progressive dividend policy, lifting the payout by 1 cent per share to $1.08.

Based on the current share price, that’s a dividend yield of approximately 5.4% before franking credits, or roughly 7% including franking credits.

Of course, a high yield is only attractive if the underlying earnings can support it.

Don’t ignore dividend growth

Wesfarmers Ltd (ASX: WES) is another potential superannuation portfolio candidate.

Its dividend yield isn’t normally among the highest on the ASX. But that’s not necessarily a problem.

Wesfarmers has historically focused on reinvesting in its businesses, improving operations and allocating capital towards growth opportunities. If those investments translate into higher earnings, they could support larger dividends over time.

Foolish takeaway

Generating $50,000 a year requires meaningful capital. For example, a portfolio yielding 5% would need $1 million invested to produce $50,000 in annual income before considering tax, franking credits and changes in dividends.

The key is not simply finding the biggest yields. A diversified superannuation portfolio that combines dependable income, dividend growth, and resilient businesses may offer a more sustainable path to retirement cash flow.

The post How to build a superannuation portfolio generating $50,000 a year appeared first on The Motley Fool Australia.

More reading

• Experts name CBA and these big-name ASX 200 shares as sells this week
• Buy, hold, sell: Corporate Travel Management, Wesfarmers, Fortescue shares
• With no savings at 50, I’d follow Warren Buffett’s approach to build wealth
• Where to invest $5,000 into ASX dividend shares
• How much superannuation do I need to earn $80,000 per year in passive income?

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has positions in and has recommended Apa Group. The Motley Fool Australia has recommended Sonic Healthcare and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.